289 related articles for article (PubMed ID: 24903928)
1. Linezolid in the treatment of drug-resistant tuberculosis: the way forward?
Yew WW; Lange C
Int J Tuberc Lung Dis; 2014 Jun; 18(6):631-2. PubMed ID: 24903928
[No Abstract] [Full Text] [Related]
2. [The analysis of clinical data about the treatment of linezolid against tuberculosis].
Nie WJ; Chu NH
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):601-3. PubMed ID: 24252739
[No Abstract] [Full Text] [Related]
3. Linezolid for multidrug-resistant tuberculosis.
Chang KC; Leung CC; Daley CL
Lancet Infect Dis; 2012 Jul; 12(7):502-3. PubMed ID: 22742623
[No Abstract] [Full Text] [Related]
4. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
Nam HS; Koh WJ; Kwon OJ; Cho SN; Shim TS
Int J Antimicrob Agents; 2009 Jan; 33(1):92-3. PubMed ID: 18789655
[No Abstract] [Full Text] [Related]
5. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
[TBL] [Abstract][Full Text] [Related]
6. Treatment of multidrug-resistant and extensively drug-resistant tuberculosis in adolescent patients.
Rodrigues M; Brito M; Villar M; Correia P
Pediatr Infect Dis J; 2014 Jun; 33(6):657-9. PubMed ID: 24642519
[TBL] [Abstract][Full Text] [Related]
7. Linezolid for multidrug-resistant tuberculosis: How should we approach it?
Santin M
Enferm Infecc Microbiol Clin; 2016 Feb; 34(2):83-4. PubMed ID: 26795055
[No Abstract] [Full Text] [Related]
8. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Yew WW; Chang KC; Chau CH
J Antimicrob Chemother; 2009 Nov; 64(5):1119; author reply 1119-20. PubMed ID: 19666903
[No Abstract] [Full Text] [Related]
9. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
Koh WJ; Shim TS
J Antimicrob Chemother; 2009 Nov; 64(5):1119-20. PubMed ID: 19744986
[No Abstract] [Full Text] [Related]
10. Linezolid in the treatment of multidrug-resistant tuberculosis.
Schecter GF; Scott C; True L; Raftery A; Flood J; Mase S
Clin Infect Dis; 2010 Jan; 50(1):49-55. PubMed ID: 19947856
[TBL] [Abstract][Full Text] [Related]
11. Linezolid for Treating Tuberculosis: A Delicate Balancing Act.
Maartens G; Benson CA
EBioMedicine; 2015 Nov; 2(11):1568-9. PubMed ID: 26870767
[No Abstract] [Full Text] [Related]
12. Activity of linezolid-containing regimens against multidrug-resistant tuberculosis in mice.
Zhao W; Guo Z; Zheng M; Zhang J; Wang B; Li P; Fu L; Liu S
Int J Antimicrob Agents; 2014 Feb; 43(2):148-53. PubMed ID: 24290060
[TBL] [Abstract][Full Text] [Related]
13. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
Xu HB; Jiang RH; Li L; Xiao HP
Int J Tuberc Lung Dis; 2012; 16(3):358-63. PubMed ID: 22640450
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience of using clofazimine to treat multidrug-resistant tuberculosis [Correspondence].
Yoo JW; Lyu J; Lee SD; Kim WS; Kim DS; Shim TS
Int J Tuberc Lung Dis; 2013 Sep; 17(9):1243-4. PubMed ID: 23928173
[No Abstract] [Full Text] [Related]
15. Linezolid for multidrug-resistant tuberculosis.
Cox H; Ford N; Hughes J; Goemaere E
Lancet Infect Dis; 2013 Jan; 13(1):16. PubMed ID: 23257228
[No Abstract] [Full Text] [Related]
16. Can intermittent dosing optimize prolonged linezolid treatment of difficult multidrug-resistant tuberculosis?
Chang KC; Yew WW; Cheung SW; Leung CC; Tam CM; Chau CH; Wen PK; Chan RC
Antimicrob Agents Chemother; 2013 Jul; 57(7):3445-9. PubMed ID: 23650165
[TBL] [Abstract][Full Text] [Related]
17. Linezolid for multidrug-resistant tuberculosis - authors' reply.
Chang KC; Leung CC; Daley CL
Lancet Infect Dis; 2013 Jan; 13(1):16-7. PubMed ID: 23257227
[No Abstract] [Full Text] [Related]
18. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
[No Abstract] [Full Text] [Related]
19. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Coban AY; Bilgin K; Uzun M; Durupinar B
Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
